PAMA: Is your lab ready for cuts of up to 15 percent on January 1?
Section 216 of the Protecting Access to Medicare Act of 2014 (PAMA) was intended to reduce Medicare spending on lab testing by implementing a market-based fee schedule and was prompted by the recognition that Medicare was paying higher rates for many tests than were private payers.[1] - Next phase in of up to 15 percent [...] Read More